According to MarketsandMarkets™, the Next-Generation Sequencing Market is projected to grow from about USD 14.94 billion in ...

According to Nova One Advisor, the global next-generation sequencing market size is calculated at USD 17.37 billion in 2026 ...

According to MarketsandMarkets, the Next-Generation Sequencing Market is projected to grow from about USD 14.94 billion in 2025 to USD 29.53 ...

The landscape of next-generation sequencing (NGS) continues to be defined by astonishing technological progress. We continue to witness sequencer throughput expansion with systems like the Illumina ...

Validated next-generation sequencing soon will become necessary in ensuring the safety and efficacy of cell and gene therapies while helping scientists to streamline quality-control processes with a ...

Routine newborn screening (NBS) has transformed early disease detection. However, traditional biochemical tests limit the range of conditions that can be identified at birth. Next-generation ...

Full-year sales for Roche’s diagnostics division were up by just 2% as the Big Pharma deals with ongoing challenges in China.  | Full-year sales for Roche’s diagnostics division were up by just 2% as ...

Roche reported 2025 sales of CHF 61.5 billion, driven by strong drug demand, rising profits, higher EPS, and a proposed ...

UC Riverside led mouse study finds microplastics affect male and female offspring differently. Researchers at the, Riverside ...

A novel liquid biopsy technology is set to advance cancer diagnostics and monitoring by overcoming the long-standing ...

NeoGenomics is transitioning from a commodity diagnostic provider to a comprehensive precision oncology platform. Read why ...

Diploid Genomics, Inc. (DGI), an AI-driven advanced genomics analytics company, launches in partnership with Healthier Capital, a leading health-tech venture capital firm, under the leadership of ...